← Open Payments lookup

JAMES BROWN: Open Payments

NPI 1013787985 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,455 in 93 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $436 · 2025 $1,455

Food & beverage: $1,455
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.18$278
Neurocrine BioSciences, Inc.13$176
Vanda Pharmaceuticals Inc.12$168
ABBVIE INC.10$163
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$152
Alkermes, Inc.11$151
Otsuka America Pharmaceutical, Inc.10$149
Janssen Pharmaceuticals, Inc4$111
Teva Pharmaceuticals USA, Inc.5$91
Axsome Therapeutics, Inc.1$15

Products named: COBENFY, INGREZZA, FANAPT, VRAYLAR, CAPLYTA, REXULTI, INVEGA SUSTENNA, LYBALVI.

Industry payments across FL — which companies pay providers there.